Crowdonomics
All companies
Nemucore Medical Innovations, Inc. logo

Nemucore Medical Innovations, Inc.

Operating

Healthcare · Wellesley, MA

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$0
Across 1 round since 2018

Financials

FY2015–FY2016 · from SEC filings · hover any figure for its source
$1.3M
−$774K
2015
$212K
−$976K
2016
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed*
FY2016 reviewed*
Income statement
Revenue
$1,273,674
$212,232
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$773,565
-$976,210
Taxes paid
$0
$0
Balance sheet
Cash
$83,934
$1,675
Accounts receivable
$37,694
$125
Total assets
$378,799
$93,746
Short-term debt
$490,517
$591,535
Long-term debt
$0
$0
Total liabilities
$490,517
$591,535
Other
Headcount
—
4

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · SAFE · Feb 2018Closedvia WeFunder
Raised $0 / $1.1M

Team

7 people
Tim ColemanFounder
Founder and CEO
David Williams
Sr. VP of Operations
Nicole A Stephenson
Secretary and Director of Operations
Michael V Seiden
Board of Directors, Nemucore Medical Innovations
Bryan Costantino
Director
Douglas G. Bailey
Director
James B Farinholt Jr
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AMay 1, 20180001670254-18-000213
    EDGAR
  • Form CFeb 28, 20180001670254-18-000057
    EDGAR
Source: SEC EDGARCIK 0001731489DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.